Royal Bank of Canada Portfolio holdings
Royal Bank of Canada (RBC), founded in 1864 and headquartered in Toronto, is Canada’s largest bank by market capitalization and one of the leading financial institutions in North America, offering a comprehensive suite of services including personal and commercial banking, wealth management, insurance, and capital markets. Managing hundreds of billions in assets, RBC serves millions of clients globally, with a significant presence in the U.S. and Caribbean through subsidiaries like RBC Wealth Management and City National Bank. Known for its stability and consistent profitability, RBC has earned a reputation as a conservative yet innovative bank, expanding its digital offerings and sustainability initiatives in recent years. With a strong focus on customer service and a robust international footprint, RBC remains a cornerstone of the Canadian and global financial systems.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Canadian Natural Resources
CNQ
|
+$1.33B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$985M |
| 3 |
Eli Lilly
LLY
|
+$901M |
| 4 |
Toronto Dominion Bank
TD
|
+$796M |
| 5 |
Blackrock
BLK
|
+$544M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HCA Healthcare
HCA
|
+$857M |
| 2 |
NVIDIA
NVDA
|
+$803M |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$676M |
| 4 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$671M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$611M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.21% |
| 2 | Technology | 15.76% |
| 3 | Industrials | 7.12% |
| 4 | Healthcare | 6.97% |
| 5 | Consumer Discretionary | 6.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5926
TFS Financial
TFSL
$4.96B
| $15K | ﹤0.01% |
1,185
-252
| -18% | -$3.23K |
|
5927
US GoldMining
USGO
$122M
| $15K | ﹤0.01% |
1,545
+1,000
| +183% | +$9.83K |
|
5928
AdvisorShares Pure Cannabis ETF
YOLO
$32.8M
| $15K | ﹤0.01% |
8,365
+260
| +3% | +$562 |
|
|
FVR
5929
FrontView REIT
FVR
$483M
| $15K | ﹤0.01% |
1,168
-682
| -37% | -$11.1K |
|
|
AGS
5930
DELISTED
PlayAGS
AGS
| $14K | ﹤0.01% |
1,145
-313
| -21% | -$3.76K |
|
5931
Ardelyx
ARDX
$1.04B
| $14K | ﹤0.01% |
2,817
-3,305
| -54% | -$17.7K |
|
5932
ATN International
ATNI
$489M
| $14K | ﹤0.01% |
665
-738
| -53% | -$13.2K |
|
5933
Avantis Responsible US Equity ETF
AVSU
$491M
| $14K | ﹤0.01% |
+226
| New | +$15K |
|
5934
Criteo S.A. Ordinary Shares
CRTO
$933M
| $14K | ﹤0.01% |
391
+93
| +31% | +$3.61K |
|
5935
Xtrackers FTSE Developed ex US Multifactor ETF
DEEF
$56.6M
| $14K | ﹤0.01% |
+459
| New | +$13.6K |
|
5936
Entravision Communication
EVC
$838M
| $14K | ﹤0.01% |
6,555
-2,498
| -28% | -$5.46K |
|
5937
Monte Rosa Therapeutics
GLUE
$1.33B
| $14K | ﹤0.01% |
3,151
-2,452
| -44% | -$15K |
|
|
GPMT
5938
Granite Point Mortgage Trust
GPMT
$57.8M
| $14K | ﹤0.01% |
5,429
-3,581
| -40% | -$10.2K |
|
5939
J. Jill
JILL
$279M
| $14K | ﹤0.01% |
743
-474
| -39% | -$11.4K |
|
5940
Lisata Therapeutics
LSTA
$10.4M
| $14K | ﹤0.01% |
5,912
+5,860
| +11,269% | +$15.9K |
|
|
SHCO
5941
DELISTED
Soho House & Co
SHCO
| $14K | ﹤0.01% |
2,140
| – | – |
|
5942
SELLAS Life Sciences
SLS
$2.55B
| $14K | ﹤0.01% |
13,125
+12,925
| +6,463% | +$15.3K |
|
|
STRS
5943
DELISTED
STRATUS PPTYS INC
STRS
| $14K | ﹤0.01% |
816
-151
| -16% | -$2.86K |
|
5944
Treace Medical Concepts
TMCI
$310M
| $14K | ﹤0.01% |
1,551
+65
| +4% | +$584 |
|
5945
USCB Financial Holdings
USCB
$419M
| $14K | ﹤0.01% |
772
-708
| -48% | -$13.2K |
|
5946
VirnetX Holding Corp
VHC
$63.2M
| $14K | ﹤0.01% |
1,875
| – | – |
|
|
VLRS
5947
Controladora Vuela Compania de Aviacion
VLRS
$904M
| $14K | ﹤0.01% |
2,609
+2,486
| +2,021% | +$17.9K |
|
5948
Arteris
AIP
$1.39B
| $13K | ﹤0.01% |
1,874
+195
| +12% | +$1.86K |
|
5949
Annexon
ANNX
$863M
| $13K | ﹤0.01% |
6,834
-5,466
| -44% | -$18.2K |
|
5950
iPath Select MLP ETN
ATMP
$647M
| $13K | ﹤0.01% |
437
| – | – |
|
Similar funds
Royal Bank of Canada's Q1 2025 Portfolio in Review
As of Q1 2025, Royal Bank of Canada held 7,428 positions worth $479B, down 4.4% from $501B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Royal Bank of Canada's Q1 2025 filing shows 373 new, 3,020 increased, 3,038 reduced and 434 closed positions. Its largest new stake was Sandisk: 233,868 shares worth $11.1M. The largest sale was HCA Healthcare, an estimated $857M.
By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 18% a quarter earlier, followed by Technology and Industrials.
- Royal Bank of Canada's largest Q1 2025 buy was Sandisk: 233,868 shares worth $11.1M.
- Royal Bank of Canada added most to Canadian Natural Resources in Q1 2025, an estimated $1.33B increase.
- Royal Bank of Canada's biggest Q1 2025 reduction was HCA Healthcare, cutting an estimated $857M.
- Royal Bank of Canada fully exited Aspen Technology Inc in Q1 2025, selling an estimated $42.5M.
- Royal Bank of Canada's ten largest holdings make up 19% of its $479B portfolio in Q1 2025.
- Royal Bank of Canada opened 373 new positions and closed 434 in Q1 2025.
- Royal Bank of Canada's portfolio value fell 4.4% quarter-over-quarter to $479B.
Based on Royal Bank of Canada's 13F filing for Q1 2025, filed 15 May 2025.